|
 |
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular & Cellular Proteomics 5:157-171, 2006.
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc.
Research
Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach*,S
,
,,,¶,||,
,¶,||,
From the McKusick-Nathans Institute of Genetic Medicine and the Department of Biological Chemistry, The Johns Hopkins University, Baltimore, Maryland 21205, the Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark, and the ¶ Department of Pathology and The Sol Goldman Pancreatic Cancer Research Center and the || Department of Oncology, The Johns Hopkins University, Baltimore, Maryland 21287
Quantitative proteomics can be used as a screening tool for identification of differentially expressed proteins as potential biomarkers for cancers. Candidate biomarkers from such studies can subsequently be tested using other techniques for use in early detection of cancers. Here we demonstrate the use of stable isotope labeling with amino acids in cell culture (SILAC) method to compare the secreted proteins (secretome) from pancreatic cancer-derived cells with that from non-neoplastic pancreatic ductal cells. We identified 145 differentially secreted proteins (>1.5-fold change), several of which were previously reported as either up-regulated (e.g. cathepsin D, macrophage colony stimulation factor, and fibronectin receptor) or down-regulated (e.g. profilin 1 and IGFBP-7) proteins in pancreatic cancer, confirming the validity of our approach. In addition, we identified several proteins that have not been correlated previously with pancreatic cancer including perlecan (HSPG2), CD9 antigen, fibronectin receptor (integrin ß1), and a novel cytokine designated as predicted osteoblast protein (FAM3C). The differential expression of a subset of these novel proteins was validated by Western blot analysis. In addition, overexpression of several proteins not described previously to be elevated in human pancreatic cancer (CD9, perlecan, SDF4, apoE, and fibronectin receptor) was confirmed by immunohistochemical labeling using pancreatic cancer tissue microarrays suggesting that these could be further pursued as potential biomarkers. Lastly the protein expression data from SILAC were compared with mRNA expression data obtained using gene expression microarrays for the two cell lines (Panc1 and human pancreatic duct epithelial), and a correlation coefficient (r) of 0.28 was obtained, confirming previously reported poor associations between RNA and protein expression studies.
Supported by a Beckman Young Investigator Award, a Sidney Kimmel Scholar Award, and National Institutes of Health Grant U54 RR020839. To whom correspondence should be addressed. Tel.: 410-502-6662; Fax: 410-502-7544; E-mail: pandey{at}jhmi.edu
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Wang and D.-J. Jang Protein Kinase CK2 Regulates Cytoskeletal Reorganization during Ionizing Radiation-Induced Senescence of Human Mesenchymal Stem Cells Cancer Res., October 15, 2009; 69(20): 8200 - 8207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Menon, Q. Zhang, Y. Zhang, D. Fermin, N. Bardeesy, R. A. DePinho, C. Lu, S. M. Hanash, G. S. Omenn, and D. J. States Identification of Novel Alternative Splice Isoforms of Circulating Proteins in a Mouse Model of Human Pancreatic Cancer Cancer Res., January 1, 2009; 69(1): 300 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhong, J. Roybal, R. Chaerkady, W. Zhang, K. Choi, C. A. Alvarez, H. Tran, C. J. Creighton, S. Yan, R. M. Strieter, et al. Identification of Secreted Proteins that Mediate Cell-Cell Interactions in an In vitro Model of the Lung Cancer Microenvironment Cancer Res., September 1, 2008; 68(17): 7237 - 7245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Peinado, G. Moreno-Bueno, D. Hardisson, E. Perez-Gomez, V. Santos, M. Mendiola, J. I. de Diego, M. Nistal, M. Quintanilla, F. Portillo, et al. Lysyl Oxidase-Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas Cancer Res., June 15, 2008; 68(12): 4541 - 4550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Qi, J Han, Y Cui, M Zong, X Liu, and B Zhu Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas J. Clin. Pathol., January 1, 2008; 61(1): 49 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Chen, T. A. Brentnall, S. Pan, K. Cooke, K. W. Moyes, Z. Lane, D. A. Crispin, D. R. Goodlett, R. Aebersold, and M. P. Bronner Quantitative Proteomics Analysis Reveals That Proteins Differentially Expressed in Chronic Pancreatitis Are Also Frequently Involved in Pancreatic Cancer Mol. Cell. Proteomics, August 1, 2007; 6(8): 1331 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Ding, A. Lambrechts, M. Parepally, and P. Roy Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis J. Cell Sci., October 1, 2006; 119(19): 4127 - 4137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Dieterich, A. J. Link, J. Graumann, D. A. Tirrell, and E. M. Schuman Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT) PNAS, June 20, 2006; 103(25): 9482 - 9487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jimeno and M. Hidalgo Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. Mol. Cancer Ther., April 1, 2006; 5(4): 787 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.A. TUVESON and S.R. HINGORANI Ductal Pancreatic Cancer in Humans and Mice Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 65 - 72. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |